The Genetic Basis of Human Craniosynostosis Syndromes
Total Page:16
File Type:pdf, Size:1020Kb
25'1ò.q,8 .{ |ì Á. The Genetic Basis of Human Craniosynostosis syndromes. Georgina Hollway BSc. (Hons.) Department of Paediatrics University of Adelaide A thesis submitted for the degree of Doctor of PhilosoPhy April 1998 ll TABLE OF CONTENTS Page Summary iv Declaration vi List of Publications vii Abbreviations viii Acknowledgments X Chapter l: Introduction I Chapter 2.Matenals and Methods 25 Chapter 3: Linkage Mapping of a Craniosynostosis Syndrome 43 Chapter 4: Mutation Search inMSXI 62 Chapter 5: Mutation Detection inFGFR3 86 Chapter 6: Exploration of the Functional Implications of the Pro25OArg Mutation of FGFR3 by High Sensitivity Immunofluoresence Flow Cytometry tt7 Chapter 7: Mutation Detection in FGFR2 and Identification of 3 Novel Mutations 736 Chapter 8: Mutation Screening inFGFS t67 111 Chapter 9: Detection of the Pro25OArg Mutation of FGFR3 m patients with Craniosynostosis and Deafness 180 Chapter 10. Conclusion 190 References 195 Appendices 1V SUMMARY Craniosynostosis is the premature fusion of one or more sutures of the skull. This can result in the distortion of the shape of the head and face, and affects an estimated 0.25 to 1.6 children per 1,000 live births. The aims of this project were to identify genes involved in craniosynostosis and to characterise mutations of these genes. To this end, linkage mapping was undertaken in a craniosynostosis pedigree and a gene was localised to chromosomal region 4p16, distal to the marker D45394. This interval contained two plausible candidate genes, MSXI and FGFR3. The localisation to 4pl6 was the first evidence for the presence of a craniosynostosis syndrome in this region of the genome. These candidate genes were screened for mutations using single strand confirmation analysis, heteroduplex analysis and sequencing. Three polymorphisms were identified in MSXI; however, no mutations were detected. Two polymorphisms were identified in FGFR3 before a candidate mutation in FGFR3 was found in a number of craniosynostosis patients, by researchers in North America. This mutation, C749G in FGFR3 (Pro250Arg) was then demonstrated to segregate with the affected members of the craniosynostosis pedigree localised to chromosomal region 4p16. Thg mutation was found in a further large pedigree in which autosomal deafness was the major feature, suggesting that the Pro25l{rg mutation may account for a proportion of autosomal dominant deafüess in the population. The Pro25gArg mutation of FGFR3 was found in fìve additional unrelated patients and is now recognised as a relatively cofltmon recurrent mutation among patients presenting to craniofacial clinics. Determination of the molecular defect responsible for this craniosynostosis syndrome, led to an investigation of the effect of the mutation on the protein and how it results in craniosynostosis. Antisera to part of the extracellular region of the FGFR3 protein were used in flow cytometry experiments on skin fibroblast cells from an affected member of the craniosynostosis pedigree and from normal controls. The hypothesis was that the receptors V from affected and unaffected cells would be distinguishable in this way, to allow further investigation. However, it was not possible to reliably detect a difference. In parallel to the FGFR3 craniosynostosis study, patients with a clinical diagnosis consistent with FGFR2 craniosynostosis syndromes were examined for molecular defects. FGFR2 mutations were found n 12 unrelated Apert patients, 8 unrelated Crouzon patients, 3 unrelated Pfeiffer patients and 6 unrelated patients with uncertain diagnoses. Three of the mutations found were novel; T8754, T797C and G(-l)C (a splice site mutation). Characterisationof FGFR2 mutations will identify which regions of the gene are functionally important and will form the basis for the study of the genotype-phenotype relations in craniosynostosis disorders. The genes causing Apert, Crouzon, Jackson Weiss, Pfeiffer and Saethre Chotzen syndromes were identified, by others, while this project was proceeding. Work carried out by the candidate and others during the course of this project elucidated the genetic basis for Craniosynostosis Adelaide Type (FGFR3 craniosynostosis). In addition, the candidate characterised FGFR2 craniosynostosis mutations to further elucidate the molecular genetic basis for that group ofdisorders. vl DECLARATION accepted for the award of any other degree This thesis contains no material which has been institution and, to the best of my knowledge or dþloma in any university or other tertiary person' previously published or written by another and beliet this thesis contains no material in the text' except where due reference has been made deposited in the University Library' being I give consent to this copy of my thesis, when available for loan and photocopying' refers to Georgina Hollway' Throughout the thesis, the term'the candidate' GEORGINAHOLLWAY 30.4.98 vll LIST OF PUBLICATIONS Some of the work presented in this thesis has been published, or accepted for publication and is in press. Reprints or final manuscripts as accepted for publication of these papers are included as appendices to this thesis. Hollway, G.E. , Phillips, H.4., Ades, L.C.,Haan E.A. and Mulley, J.C. (1995) Localisation of craniosynostosis Adelaide type to 4p16. Human Molecular Genetics 4,681-683. Hollway, G.8., Suthers, G.K., Haan, E.4., Thompson, 8., David, DJ., Gecz, J. and Mulley, J.C. (1997) Mutation detection in FGFR2 craniosynostosis syndromes. Human Genetics 99,251-255. Muenke, M., Gripp, K.W., McDonald-McGinn, D.M., Gaudenz, K., Whitaker, L.4., Bartlett, S.P., Markowitz, R.I., Robin, N.H., Nwokoro, N., Mulvihill, J.J., Losken, H.Vy'., Mulliken, J.8., Guttmacher, A.8., V/ilroy, R.S., Clarke, L.4., HollwãY, G., Adès, L.C.,Haan, E.4., Mulley, J.C., Cohen Jr, M.M., Bellus, G.4., Francomano, C.4., Moloney, D.M., Wall, S.4., Wilkie, A.O.M. and Zackai, E.H. (1997) A unique point mutation in the Fibroblast Growth Factor Receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. American Journal of Human Genetics 60,555-564. Hollway, G.E., Suthers, G.K., Battese, K.M., Turner, 4.M., David, D'.J. and Mulley, J.C. (1998) Deafness due to Pro25l{rg mutation of FGFR3. The Lancet 351,877-878 Hollway, G.E. and Mulley, J.C. Polymorphic Variants within the HomeoboxGeneMSXl Clinical Genetics - accepted for publication. vl11 ABBRE\rIATIONS A - adenine ¡cr "lldctP - alphalabelled deoxyadenosine triphosphate AC - dinucleotide repeat microsatellite ACH - achondroplasia bp, Kb - base pairs, kilobase pairs C - cytosine CAT - Craniosynostosis Adelaide type Ci, pCi - Curies, micro Curies cM - centimorgan (the genetic distance within which there is expected to be one crossover every 100 meioses) CEPH - Centre d'Etude du Polymorphisme Humain (Centre for the Study of Human Polymorphism) CHRI - Child Health Research Institute, WCH, North Adelaide, South Australia CVS - chorionic villus sample EDTA - ethylenediaminetetra-acetic acid FGF - fibroblast growth factor FGFR - fibroblast growth factor receptor G - guanine g, frB,ug, trg, pg - gram) milligram, microgram, nanogram, picogram HA - heteroduplex analysis IPTG - isopropylthio B -galacto side JW - Jackson Weiss JWS - Jackson Weiss syndrome l, ml, pl - litre, millilitre, microlitre LCL - lymphoblastoid cell line (derived from a eukaryotic cell) lod score - the decimal logarithm of the likelihood ratio of linkage versus no linkage M, mM - moles per litre, millimoles per litre MDE - mutation detection enhancement 1X MgCl2 - magnesium chloride NaAc - sodium acetafe NaNO¡ - sodium nitrate NIH - National Institutes of Health OD260 - optical density at 260 nanometres PCR - polymerase chain reaction PE-SA - phycoerythrin conjugated to streptavidin pH - negative logarithm of the hydrogen ion concentration (in moles per litre) RFLP - restriction fragment polymorphism rpm - revolutions per minute RT - reverse transcriptase RT PCR - reverse transcription polymerase chain reaction SCS - Saethre Chotzen syndrome SDS - sodium dodecyl sulphate SPSS sequencing - solid phase single strand sequencing SSCA (SSCP) - single stranded conformation analysis (polymorphism) T - thymidine TD - thanatophoric dysplasia TEMED - tetramethylethylenediamine Tris - tris[hydroxymethyl]amino methane VNTR - variable number of tandem repeats (also known as minisatellite) WCH - Women's and Children's Hospital, North Adelaide, South Australia X-gal - 5-bromo-4-chloro-3-indoyl-B-galactoside x ACKNOWLEDGMENTS The work presented in this thesis was carried out in the Department of Cytogenetics and Molecular Genetics at the Women's and Children's Hospital, Adelaide. I am grateful for the financial support I received from an Australian Postgraduate Award and from the Department of Cytogenetics and Molecular Genetics. I would like to thank my principal supervisor Dr John Mulley for his advice, encouragement and humour throughout this project. I would also like to thank Prof Grant Sutherland for the opportunity to conduct this research in the department and for his valuable advice. Many clinicians have contributed to this project and their work was essential for the project to proceed. In particular I would like to thank Dr Graeme Suthers for his keen interest in the craniosynostosis research. I am extremely grateful to Prof Heddy Zola fot allowing me to conduct flow cytometry experiments in the Child Health Research Institute, and for many of the reagents necessary for this. I am also very grateful to Prof Michael Hayman for sending a sample of the 58141 antiserum fromNew